VIDO-InterVac COVID-19 vaccine moving to first phase of clinical trial
The COVID-19 vaccine created at Saskatoon’s VIDO-InterVac facility has received Health Canada approval to move to initiate Phase 1 clinical vaccine trial. VIDO Director and CEO Dr. Voker Gerdts says this is the first of their two COVID-19 subunit vaccines in development. Officials explained that subunit-based vaccines are a proven technology, that has been used […]